Johnson & Johnson (JNJ) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156384,
    "name": "Johnson & Johnson",
    "stock_name": "Johnson & Johnson",
    "full_name": "Johnson & Johnson",
    "name_url": "stocks-analysis/johnson-johnson",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "202.48",
    "chg": -2.85,
    "chgp": "-1.39%",
    "dir": -1,
    "prev_price": "205.33",
    "mcapval": "515,810.48",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US4781601046",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.52 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/johnson-johnson-1156384-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Johnson & Johnson Hits New 52-Week High at USD 190.22",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-johnson-hits-new-52-week-high-at-usd-19022-3607941",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/JohnsonJohnson_priceRelatedfactors_3607941.png",
        "date": "2025-10-09 19:53:30",
        "description": "Johnson & Johnson achieved a new 52-week high of USD 190.22 on October 8, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant growth over the past year, with a solid market capitalization and favorable financial metrics, indicating effective resource management."
      },
      {
        "title": "Johnson & Johnson Hits New 52-Week High at $189.92, Showcasing Strong Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-johnson-hits-new-52-week-high-at-18992-showcasing-strong-growth-3601514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/JohnsonJohnson_priceRelatedfactors_3601514.png",
        "date": "2025-10-07 21:33:06",
        "description": "Johnson & Johnson achieved a new 52-week high of USD 189.92 on October 6, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a notable stock price increase over the past year, supported by solid financial metrics and a substantial market capitalization."
      },
      {
        "title": "Johnson & Johnson Hits New 52-Week High at USD 189.78",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-johnson-hits-new-52-week-high-at-usd-18978-3595535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/JohnsonJohnson_priceRelatedfactors_3595535.png",
        "date": "2025-10-06 17:20:19",
        "description": "Johnson & Johnson achieved a new 52-week high of USD 189.78 on October 3, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant growth over the past year, with a solid market capitalization and favorable financial metrics, indicating effective resource management and profitability."
      },
      {
        "title": "Johnson & Johnson Hits New 52-Week High at $186.55, Up 26.45%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-johnson-hits-new-52-week-high-at-18655-up-2645-3588293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/JohnsonJohnson_priceRelatedfactors_3588293.png",
        "date": "2025-10-02 22:24:41",
        "description": "Johnson & Johnson achieved a new 52-week high of USD 186.55 on October 1, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 26.45% growth over the past year, significantly outperforming the S&P 500, and maintains solid financial metrics."
      },
      {
        "title": "Johnson & Johnson Hits New 52-Week High at $185.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-johnson-hits-new-52-week-high-at-18599-3585969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/JohnsonJohnson_priceRelatedfactors_3585969.png",
        "date": "2025-10-01 16:29:15",
        "description": "Johnson & Johnson achieved a new 52-week high of USD 185.99 on September 30, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 26.02% growth over the past year, with a market capitalization of USD 515.81 billion and a solid financial foundation."
      },
      {
        "title": "Johnson & Johnson Hits Day High with Strong 3.18% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-johnson-hits-day-high-with-strong-318-intraday-surge-3585847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/JohnsonJohnson_priceRelatedfactors_3585847.png",
        "date": "2025-10-01 16:07:35",
        "description": "Johnson & Johnson's stock has shown strong performance, significantly outperforming the S&P 500 over various time frames. The company maintains a robust financial position, characterized by a low Debt to EBITDA ratio and a high Return on Capital Employed, alongside a solid dividend yield and substantial institutional holdings."
      },
      {
        "title": "Is Johnson & Johnson technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-johnson-johnson-technically-bullish-or-bearish-3545161",
        "imagepath": "",
        "date": "2025-09-20 19:05:03",
        "description": "As of 24 July 2025, the technical trend for Johnson & Johnson has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, supporting the positive trend. Daily moving averages also indicate a bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, and the On-Balance Volume (OBV) is mildly bearish on a weekly basis but bullish monthly. \n\nIn terms of performance, Johnson & Johnson has underperformed the S&P 500 over the past week and month, with returns of -2.43% and -1.19% respectively, while the S&P 500 gained 1.05% and 2.33%. However, year-to-date, the stock has outperformed the benchmark with a return of 20.43% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish, albeit with some mixed signals from certain indicators...."
      },
      {
        "title": "Is Johnson & Johnson overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-johnson-johnson-overvalued-or-undervalued-3541882",
        "imagepath": "",
        "date": "2025-09-20 17:38:44",
        "description": "As of 16 July 2025, the valuation grade for Johnson & Johnson has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently considered fairly valued. Key valuation ratios include a P/E ratio of 23, an EV to EBITDA of 16.16, and a Price to Book Value of 5.74. In comparison, Eli Lilly & Co. has a higher P/E of 40.89, while Merck & Co., Inc. shows a more attractive P/E of 15.68.\n\nDespite the recent downgrade in valuation, Johnson & Johnson has outperformed the S&P 500 year-to-date with a return of 20.43% compared to the index's 12.22%. However, over longer periods, such as the 3-year and 5-year returns, the company has lagged behind the S&P 500, with returns of 3.91% and 16.74% respectively, compared to the index's 70.41% and 96.61%...."
      }
    ],
    "total": 13,
    "sid": "1156384",
    "stock_news_url": "https://www.marketsmojo.com/news/johnson-johnson-1156384"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Johnson & Johnson Hits New 52-Week High at USD 190.22

2025-10-09 19:53:30

Johnson & Johnson achieved a new 52-week high of USD 190.22 on October 8, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant growth over the past year, with a solid market capitalization and favorable financial metrics, indicating effective resource management.

Johnson & Johnson Hits New 52-Week High at $189.92, Showcasing Strong Growth

2025-10-07 21:33:06

Johnson & Johnson achieved a new 52-week high of USD 189.92 on October 6, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a notable stock price increase over the past year, supported by solid financial metrics and a substantial market capitalization.

Johnson & Johnson Hits New 52-Week High at USD 189.78

2025-10-06 17:20:19

Johnson & Johnson achieved a new 52-week high of USD 189.78 on October 3, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen significant growth over the past year, with a solid market capitalization and favorable financial metrics, indicating effective resource management and profitability.

Johnson & Johnson Hits New 52-Week High at $186.55, Up 26.45%

2025-10-02 22:24:41

Johnson & Johnson achieved a new 52-week high of USD 186.55 on October 1, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 26.45% growth over the past year, significantly outperforming the S&P 500, and maintains solid financial metrics.

Johnson & Johnson Hits New 52-Week High at $185.99

2025-10-01 16:29:15

Johnson & Johnson achieved a new 52-week high of USD 185.99 on September 30, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 26.02% growth over the past year, with a market capitalization of USD 515.81 billion and a solid financial foundation.

Johnson & Johnson Hits Day High with Strong 3.18% Intraday Surge

2025-10-01 16:07:35

Johnson & Johnson's stock has shown strong performance, significantly outperforming the S&P 500 over various time frames. The company maintains a robust financial position, characterized by a low Debt to EBITDA ratio and a high Return on Capital Employed, alongside a solid dividend yield and substantial institutional holdings.

Is Johnson & Johnson technically bullish or bearish?

2025-09-20 19:05:03

As of 24 July 2025, the technical trend for Johnson & Johnson has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, supporting the positive trend. Daily moving averages also indicate a bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, and the On-Balance Volume (OBV) is mildly bearish on a weekly basis but bullish monthly. In terms of performance, Johnson & Johnson has underperformed the S&P 500 over the past week and month, with returns of -2.43% and -1.19% respectively, while the S&P 500 gained 1.05% and 2.33%. However, year-to-date, the stock has outperformed the benchmark with a return of 20.43% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish, albeit with some mixed signals from certain indicators....

Is Johnson & Johnson overvalued or undervalued?

2025-09-20 17:38:44

As of 16 July 2025, the valuation grade for Johnson & Johnson has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently considered fairly valued. Key valuation ratios include a P/E ratio of 23, an EV to EBITDA of 16.16, and a Price to Book Value of 5.74. In comparison, Eli Lilly & Co. has a higher P/E of 40.89, while Merck & Co., Inc. shows a more attractive P/E of 15.68. Despite the recent downgrade in valuation, Johnson & Johnson has outperformed the S&P 500 year-to-date with a return of 20.43% compared to the index's 12.22%. However, over longer periods, such as the 3-year and 5-year returns, the company has lagged behind the S&P 500, with returns of 3.91% and 16.74% respectively, compared to the index's 70.41% and 96.61%....

View All News